There were no significant differences in the nuclear RAD21 expression between BRCA1 (12 (43%) of 28), BRCA2 (12 (44%) of 27), and BRCAX cancers (12 (33%) of 39 (p = 0.598). This evidence concerns the gene BRCA2 and cancer.